TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2688971

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 594

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 594
Study: 30862961

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH) at 33.5 °C for 72 h in OC trial
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH) at 33.5 °C for 72 h in IH trial
Number of subjects: 572

Group type: COMPARATOR
Intervention: OC trial (cooling to 33.5 °C for 72 h)
Number of subjects: 572

Group type: COMPARATOR
Intervention: IH trial
Number of subjects: 572
Study: 28635634

Group type: EXPERIMENTAL
Intervention: 4 + 4 g/day oral EAAs
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 26233286

Group type: EXPERIMENTAL
Intervention: Decorated objects (e.g., polka dots, feathers)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Plain and monochromatic objects
Number of subjects: 67
Study: 23906876

Group type: EXPERIMENTAL
Intervention: Mitral valve replacement (MVR) in group 1 (PAP < 50 mmHg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Mitral valve replacement (MVR) in group 2 (PAP ≥ 50 mmHg)
Number of subjects: 25
Study: 21210776

Group type: EXPERIMENTAL
Intervention: Berlin-Frankfürt-Münster-derived acute lymphoblastic leukaemia (ALL) therapy
Number of subjects: 53
Study: 18241972

Group type: EXPERIMENTAL
Intervention: FAED
Number of subjects: 176

Group type: COMPARATOR
Intervention: SAED
Number of subjects: 176
Study: 17243596

Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond (CPB, Kuraray)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: G‐Bond (GBO, GC)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Hybrid Bond (HYB, Sun Medical)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: iBond NG experimental (ING, Heraeus Kulzer)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Clearfil S3 Bond (TSB, Kuraray)
Number of subjects: 320
Study: 15504183

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.03 mg kg(‐1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 120
Study: 11549539

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (250 mg of vitamin C, 50 IU of alpha-tocopherol, and 12 oz of vegetable cocktail daily for 2 weeks)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 9029389

Group type: EXPERIMENTAL
Intervention: Cefazolin administered preoperatively (1 g)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cefazolin administered after cord clamping (1 g)
Number of subjects: 90
Study: 8299661

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg once a day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 3571079

Group type: EXPERIMENTAL
Intervention: Exercise training group (n = 40)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (n = 49)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 89
Study: 30548375

Group type: EXPERIMENTAL
Intervention: Metacognitive Reflection and Insight Therapy (MERIT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for psychosis (CBTp) or Metacognition‐Oriented Social Skills training
Number of subjects: 14
Study: 30554366

Group type: COMPARATOR
Intervention: Control treatment based on P. purpureum (PT) grass
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Neomillspaughia emargiata (NE)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Tabernaemontana amygdalifolia (TA)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Caesalpinia gaumeri (CG)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Piscidia piscipula (PP)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Leucaena leucocephala (LL)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Havardia albicans (HA)
Number of subjects: 7
Study: 28343108

Group type: EXPERIMENTAL
Intervention: mTG-modified wheat flour rusks (n=11)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Unmodified wheat flour rusks (n=10)
Number of subjects: 21
Study: 25241089

Group type: EXPERIMENTAL
Intervention: Mycobacterium w (Mw)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study: 24287222

Group type: EXPERIMENTAL
Intervention: Patellar strap
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Sports tape
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo tape
Number of subjects: 140

Group type: COMPARATOR
Intervention: No orthosis
Number of subjects: 140
Study: 21689982

Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-obstructive sleep apnea (non-OSA)
Number of subjects: 28
Study: 18516532

Group type: EXPERIMENTAL
Intervention: PJ with an internal stent (group I)
Number of subjects: 43

Group type: COMPARATOR
Intervention: PJ with an external stent (group E)
Number of subjects: 43
Study: 16496307

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (3 g, intravenously, n = 15)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (n = 12)
Number of subjects: 37
Study: 12492803

Group type: EXPERIMENTAL
Intervention: i.v. remifentanil (1.5 micro g kg‐1, followed by 0.2 micro g kg‐1 min‐1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: i.v. sufentanil (0.2 micro g kg‐1 followed by 0.2 micro g kg‐1 h‐1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: remifentanil
Number of subjects: 50

Group type: COMPARATOR
Intervention: sufentanil
Number of subjects: 50
Study: 11736778

Group type: EXPERIMENTAL
Intervention: Epidural infusion of ropivacaine 0.1% and sufentanil 1 microg x ml(‐1) at a rate of 5‐9 ml x h(‐1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intravenous patient‐controlled analgesia using piritramide
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Epidural infusion of ropivacaine 0.1% and sufentanil 1 microg x ml(‐1)
Number of subjects: 24
Study: 9249623

Group type: EXPERIMENTAL
Intervention: EBD students
Number of subjects: 81

Group type: COMPARATOR
Intervention: Learning disabilities students
Number of subjects: 81

Group type: COMPARATOR
Intervention: Problem children (PC)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Normal children (NC)
Number of subjects: 81
Study: 8308771

Group type: EXPERIMENTAL
Intervention: recombinant interferon-gamma (rIFN-gamma)
Number of subjects: 70
Study: 2879458

Group type: EXPERIMENTAL
Intervention: 0.5 mg of ipratropium bromide
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: 1.25 mg of fenoterol hydrobromide
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: 0.5 mg of ipratropium plus 1.25 mg of fenoterol
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 199
Study: 31757776

Group type: EXPERIMENTAL
Intervention: Online self-esteem intervention (7 weekly sessions in Second Life)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (received intervention materials at the end of the study)
Number of subjects: 21
Study: 30893450

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection (IAI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laser control
Number of subjects: 0
Study: 28619115

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - 120 min/week walking (396 METs/min/week) and monthly sociocultural gatherings
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG)
Number of subjects: 364
Study: 25553559

Group type: EXPERIMENTAL
Intervention: Inverted seated position
Number of subjects: 12

Group type: COMPARATOR
Intervention: Upright seated position
Number of subjects: 12
Study: 22878057

Group type: EXPERIMENTAL
Intervention: Dorsal dartos flap rotation
Number of subjects: 17

Group type: COMPARATOR
Intervention: Suturing tunica albuginea to the pubic periosteum
Number of subjects: 17
Study: 20980335

Group type: EXPERIMENTAL
Intervention: 10 µM trabedersen
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: 80 µM trabedersen
Number of subjects: 145

Group type: COMPARATOR
Intervention: Chemotherapy (temozolomide or procarbazine/lomustine/vincristine)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Standard chemotherapy
Number of subjects: 145
Study: 18321354

Group type: EXPERIMENTAL
Intervention: Standardized group CBT
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Individual CBT
Number of subjects: 178
Study: 16582025

Group type: EXPERIMENTAL
Intervention: KRG-rootlets (6 g)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: KRG-rootlets (mean of 3 doses)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (0 g)
Number of subjects: 19
Study: 14527076

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 10780123

Group type: EXPERIMENTAL
Intervention: Nicotine transdermal patch (21 mg)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 61
Study: 8798245

Group type: COMPARATOR
Intervention: Total homocysteine (tHcy) levels in children whose father, grandfather, or uncle died at age ≤ 55 years of myocardial infarction or sudden cardiac arrest (n = 42)
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Serum folate, plasma creatinine, and sugar intake as percent of dietary energy
Number of subjects: 756
Study: 2001315

Group type: EXPERIMENTAL
Intervention: Stabilisation splint (SS)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Localised occlusal interference splint (LOIS)
Number of subjects: 68
Study: 6132630

Group type: EXPERIMENTAL
Intervention: Sublingual lorazepam
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oral lorazepam
Number of subjects: 12
Study: 31350122

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (6 weeks treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (6 weeks treatment)
Number of subjects: 0
Study: 29098250

Group type: EXPERIMENTAL
Intervention: MTA apical barrier technique
Number of subjects: 75

Group type: COMPARATOR
Intervention: Vitapex apexification
Number of subjects: 75
Study: 26519693

Group type: EXPERIMENTAL
Intervention: High cut-off dialysis
Number of subjects: 43

Group type: COMPARATOR
Intervention: High-flux dialysis
Number of subjects: 43
Study: 23254732

Group type: EXPERIMENTAL
Intervention: Dexamethasone cyclophosphamide pulse (DCP) therapy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Oral cyclophosphamide
Number of subjects: 19
Study: 20444947

Group type: EXPERIMENTAL
Intervention: Correctional boot camp
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional prison
Number of subjects: 0
Study: 19064982

Group type: EXPERIMENTAL
Intervention: Sunitinib (50 mg/d for 4 weeks, 2 weeks off)
Number of subjects: 23
Study: 17724176

Group type: EXPERIMENTAL
Intervention: Ruboxistaurin
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 15483340

Group type: EXPERIMENTAL
Intervention: Acoustic pharyngometry in four body positions (sitting, supine, right and left lateral) while awake with tidal breathing
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Acoustic pharyngometry
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Polysomnography (PSG)
Number of subjects: 70
Study: 11505259

Group type: EXPERIMENTAL
Intervention: Rigid fixation (n = 78)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Wire fixation (n = 49)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Rigid fixation with genioplasty (n = 35)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Wire fixation with genioplasty (n = 24)
Number of subjects: 127
Study: 9611933

Group type: EXPERIMENTAL
Intervention: Cavity wall finish with regular cavosurface angle
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cavity wall finish with non-standard cavosurface angle
Number of subjects: 0
Study: 8813779

Group type: EXPERIMENTAL
Intervention: French technique
Number of subjects: 49

Group type: COMPARATOR
Intervention: American technique
Number of subjects: 49
Study: 2286465

Group type: EXPERIMENTAL
Intervention: Fosfomycin trometamol (3 g)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Ofloxacin (200 mg)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Co-trimoxazole (1.92 g)
Number of subjects: 562
Study: 7240438

Group type: EXPERIMENTAL
Intervention: Aspirin (3.25 Gm/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Naproxen sodium (1.1 Gm/day)
Number of subjects: 12
Study: 30643596

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation training (SIM)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Low-fidelity CPR manikin training (STD)
Number of subjects: 70
Study: 27918854

Group type: EXPERIMENTAL
Intervention: High EF (8 eating occasions/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Low EF (3 eating occasions/day)
Number of subjects: 15
Study: 27053264

Group type: EXPERIMENTAL
Intervention: Audit-based education (ABE)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Guidelines and prompts (G&P)
Number of subjects: 4
Study: 25462140

Group type: EXPERIMENTAL
Intervention: 1 Hz right temporoparietal rTMS for 17 minutes
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 24
Study: 22001361

Group type: EXPERIMENTAL
Intervention: Web-based communication and support intervention
Number of subjects: 313
Study: 19965822

Group type: COMPARATOR
Intervention: Intravitreal bevacizumab (IVB) alone
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB) plus low fluence photodynamic therapy (PDT)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Comparison of IVB alone vs IVB plus low fluence PDT
Number of subjects: 85
Study: 17324010

Group type: EXPERIMENTAL
Intervention: Ranpirnase plus doxorubicin
Number of subjects: 360

Group type: COMPARATOR
Intervention: Doxorubicin alone
Number of subjects: 360
Study: 16062094

Group type: EXPERIMENTAL
Intervention: Risperidone (4 mg/day)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Quetiapine (400 mg/day)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Fluphenazine (12.5 mg/day)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Fluphenazine
Number of subjects: 38
Study: 11853004

Group type: EXPERIMENTAL
Intervention: Irinotecan 120 mg/m2 on days 1 + 15 plus mitomycin C 8 mg/m2 on day 1
Number of subjects: 64

Group type: COMPARATOR
Intervention: Oxaliplatin 85 mg/m2 on days 1 + 15 plus mitomycin C 8 mg/m2 on day 1
Number of subjects: 64
Study: 9022109

Group type: EXPERIMENTAL
Intervention: Mitomycin C
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study: 7957830

Group type: EXPERIMENTAL
Intervention: Budesonide (800 micrograms.day‐1) for 4 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 3109060

Group type: EXPERIMENTAL
Intervention: Low dose heparin (5000 IU twice daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no heparin)
Number of subjects: 40
Study: 31307842

Group type: EXPERIMENTAL
Intervention: HD + açaí
Number of subjects: 69

Group type: COMPARATOR
Intervention: HD + placebo
Number of subjects: 69
Study: 29043496

Group type: EXPERIMENTAL
Intervention: erlotinib plus bevacizumab
Number of subjects: 152

Group type: COMPARATOR
Intervention: erlotinib
Number of subjects: 152
Study: 26552503

Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg
Number of subjects: 76

Group type: COMPARATOR
Intervention: Thienopyridine (prasugrel 60 mg or clopidogrel 600 mg)
Number of subjects: 76
Study: 25060833

Group type: EXPERIMENTAL
Intervention: Multimodal treatment program (MTP)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Community care (treatment-as-usual, TAU)
Number of subjects: 135
Study: 21941361

Group type: EXPERIMENTAL
Intervention: Posturing group (face down for 10 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-posturing group (avoid face-up position only)
Number of subjects: 30
Study: 18353909

Group type: EXPERIMENTAL
Intervention: Multilevel school-based intervention; specific details on dosage and duration not available.
Number of subjects: 0
Study: 18713888

Group type: EXPERIMENTAL
Intervention: Propofol at 3 microg/mL
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol at 4.5 microg/mL
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol at 6 microg/mL
Number of subjects: 60
Study: 16122458

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel
Number of subjects: 201

Group type: COMPARATOR
Intervention: Traditional electrocautery and scissors
Number of subjects: 201
Study: 12588088

Group type: EXPERIMENTAL
Intervention: Higher toenail selenium concentrations (at the 75th percentile)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Low toenail selenium concentrations (lowest levels)
Number of subjects: 500
Study: 10080585

Group type: EXPERIMENTAL
Intervention: 8 months of chemotherapy with irradiation (XRT) of the primary site; 7 patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: 8 months of chemotherapy without XRT; 4 patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: 9 weeks of chemotherapy without XRT; 20 patients
Number of subjects: 31
Study: 8622038

Group type: EXPERIMENTAL
Intervention: GM‐CSF (5 to 15 micrograms/kg/d subcutaneously)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: GM‐CSF
Number of subjects: 37

Group type: COMPARATOR
Intervention: Chemotherapy alone (Control)
Number of subjects: 37
Study: 10149499

Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Conventional ultrafiltration
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control
Number of subjects: 21
Study: 6130329

Group type: EXPERIMENTAL
Intervention: Epoprostenol (prostacyclin, PGI2) infusion at 7.5 ng/kg/min after the first hour for 5 hours, administered weekly for three weeks.
Number of subjects: 14

Group type: COMPARATOR
Intervention: Buffer infusion (control group) for 5 hours, administered weekly for three weeks.
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Epoprostenol (prostacyclin, PGI2) infusion.
Number of subjects: 14
Study: 31141195

Group type: EXPERIMENTAL
Intervention: Early initiation of antiretroviral treatment (ART) within 14 days
Number of subjects: 75

Group type: COMPARATOR
Intervention: Delayed initiation of antiretroviral treatment (ART) after nutritional recovery
Number of subjects: 75
Study: 29916324

Group type: EXPERIMENTAL
Intervention: Orem's self-care model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 0
Study: 27155903

Group type: EXPERIMENTAL
Intervention: Blunt abdominal entry
Number of subjects: 13153

Group type: COMPARATOR
Intervention: Sharp abdominal entry
Number of subjects: 13153

Group type: EXPERIMENTAL
Intervention: Exteriorisation of the uterus for repair
Number of subjects: 13153

Group type: COMPARATOR
Intervention: Intra-abdominal repair
Number of subjects: 13153

Group type: EXPERIMENTAL
Intervention: Single layer closure of the uterus
Number of subjects: 13153

Group type: COMPARATOR
Intervention: Double layer closure of the uterus
Number of subjects: 13153

Group type: EXPERIMENTAL
Intervention: Closure of the peritoneum
Number of subjects: 13153

Group type: COMPARATOR
Intervention: Non-closure of the peritoneum
Number of subjects: 13153

Group type: EXPERIMENTAL
Intervention: Chromic catgut sutures
Number of subjects: 13153

Group type: COMPARATOR
Intervention: Polyglactin-910 sutures
Number of subjects: 13153
Study: 24786016

Group type: EXPERIMENTAL
Intervention: Single subcutaneous (SC) injection of 12.5 mg rhTNFR-Fc
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Single subcutaneous (SC) injection of 25 mg rhTNFR-Fc
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Single subcutaneous (SC) injection of 50 mg rhTNFR-Fc
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Six SC injections of 25 mg rhTNFR-Fc once every 3 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy Chinese subjects (control)
Number of subjects: 40
Study: 23006933

Group type: EXPERIMENTAL
Intervention: Sericin cream
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cream base (placebo)
Number of subjects: 50
Study: 20329659

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (test formulation, 250 mg/5 mL suspension)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference formulation of cefuroxime axetil
Number of subjects: 0
Study: 17545874

Group type: EXPERIMENTAL
Intervention: Videostroboscopy (VS)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: High-speed glottography (HGG)
Number of subjects: 162
Study: 16364124

Group type: EXPERIMENTAL
Intervention: Propanol-based hand rub with emollients (0.81%, w/w)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Propanol-based hand rub without emollients
Number of subjects: 35
Study: 11899906

Group type: EXPERIMENTAL
Intervention: Various dose-fractionation schedules for palliative radiotherapy
Number of subjects: 1200
Study: 9620101

Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Diclofenac 75 mg
Number of subjects: 180
Study: 8553306

Group type: EXPERIMENTAL
Intervention: Prednisone (1 mg/kg/day for 15 days and then tapering off)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 2096210

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 21
Study: 92589

Group type: EXPERIMENTAL
Intervention: Treatment with lipocaine or trimecaine (antiarrhythmic drugs)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Control group (random control group)
Number of subjects: 209
Study: 30510079

Group type: EXPERIMENTAL
Intervention: Ravulizumab (900 mg every 8 weeks)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Ravulizumab
Number of subjects: 195

Group type: COMPARATOR
Intervention: Eculizumab (900 mg every 2 weeks)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Eculizumab
Number of subjects: 195
Study: 28433518

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 10 mg/kg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline 20 mL
Number of subjects: 50
Study: 25904685

Group type: EXPERIMENTAL
Intervention: HCA+MMA
Number of subjects: 10

Group type: COMPARATOR
Intervention: HCA
Number of subjects: 10

Group type: COMPARATOR
Intervention: MMA
Number of subjects: 10
Study: 24050582

Group type: EXPERIMENTAL
Intervention: Co-supplemented hemp seed and evening primrose oils with advised Hot-nature diet
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Co-supplemented hemp seed and evening primrose oils
Number of subjects: 100

Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 100